![Chris Moreau](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chris Moreau
Algemeen Directeur bij
GREY MATTERS HEALTH INC.
Vermogen: 67 367 $ op 31-05-2026
Profiel
Christopher Joseph Moreau is currently Chief Executive Officer & Director at Grey Matters Health, Inc. since 2020.
Formerly, Mr. Moreau was Director at First Responder Technologies, Inc. from 2019 to 2020, President & Chief Executive Officer at Nash Pharmaceuticals, Inc. from 2017 to 2018, President, CEO, Director & Head-Investor Relations at Luminor Medical Technologies, Inc. from 2011 to 2015, and President at Advansis Capital Corp.
from 2004 to 2005.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-11-2025 | 212.515 ( 3,92% ) | 67 367 $ | 31-05-2026 |
Actieve functies van Chris Moreau
| Bedrijven | Functie | Begin |
|---|---|---|
| GREY MATTERS HEALTH INC. | Algemeen Directeur | 01-03-2018 |
Eerdere bekende functies van Chris Moreau
| Bedrijven | Functie | Einde |
|---|---|---|
| QUEBEC HOLDINGS PEGMATITE | President | 24-07-2019 |
Nash Pharmaceuticals, Inc.
 Nash Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Algemeen Directeur | 01-03-2018 |
Luminor Medical Technologies, Inc.
 Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Algemeen Directeur | 21-04-2016 |
Advansis Capital Corp. | President | 01-11-2005 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
22
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Commercial Services |
Advansis Capital Corp. | |
Algernon Pharmaceuticals, Inc.
 Algernon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage, drug development and repurposing company | Health Technology |
First Responder Technologies, Inc.
 First Responder Technologies, Inc. Aerospace & DefenseElectronic Technology Manufactures weapon detection devices | Electronic Technology |
Nash Pharmaceuticals, Inc.
Nash Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
